Why did the Women’s Health Initiative (WHI) make people fearful of hormone therapy, and how should its findings be interpreted today?
The Women’s Health Initiative (WHI) made people fearful of hormone therapy because its initial results, released in 2002, were widely misinterpreted and sensationalized in the media. The study reported a relative increase in risks such as breast cancer, heart disease, and stroke for women taking a specific combination of estrogen and synthetic progestin. Headlines and news coverage amplified these findings, leading to a dramatic drop in hormone therapy use—by as much as 80%—and a generation of doctors and patients became wary of menopausal hormone treatment (MHT).
However, here at Alloy, we want to emphasize that the WHI findings have since been re-evaluated and clarified:
- The increased breast cancer risk reported was actually very small in absolute terms—less than one additional case per 1,000 women per year.
- The risk was only seen with the combination of estrogen and synthetic progestin, not with estrogen alone. In fact, women who took estrogen alone had a decreased risk of breast cancer.
- The average age of women in the WHI was 63, meaning the results did not apply to women starting MHT closer to the onset of menopause (typically in their 40s or 50s).
- Many of the original claims about increased risks have been walked back by the study’s own investigators.
Today, every major medical society—including The Menopause Society and the American College of Obstetricians and Gynecologists—agrees that for the vast majority of healthy, symptomatic women, MHT is the safest and most effective treatment for menopause symptoms, and its benefits far outweigh any risks. The decision to use MHT should be individualized, based on your health profile and preferences.
For a deeper dive into how the WHI study was misinterpreted and its impact on menopause care, check out these resources:
- The Menopause Society's New Position Statement
- New England Journal of Medicine article on the WHI’s effects
- Dr. Avrum Bluming’s book, Estrogen Matters
You might also find it helpful to watch these specific YouTube chapters for expert explanations:
- Media Impact and Misinterpretation from Dr. Corinne Menn
- The WHI Study and Risk Misinterpretation from Dr. Mary Claire Haver
- The Women's Health Initiative Study with Dr. Sharon Malone
If you’re interested in learning about safe, evidence-based MHT options, visit our Alloy product page or start with our online assessment to see how we can help you feel your best. At Alloy, we’re committed to providing science-backed care and empowering you with the facts, not fear.
This answer was created using the following resources:
- Myths & Misconceptions Around Menopausal Hormone Therapy | Dr. Corinne Menn - Media Impact and Misinterpretation
- Debunking the Myth: Estrogen Therapy and Breast Cancer Risk | Dr. Mary Jane Minkin
- The New Menopause | Dr. Mary Claire Haver - The WHI Study and Risk Misinterpretation
- Menopause, Hormones & Your Heart: What You Need to Know | Dr. Jayne Morgan - Impact of the Women's Health Initiative on Menopause Care
- Big News for Menopause!
- Anne Fulendwider Recaps Alloy on the Today Show - Misconceptions from the WHI Study
- Alloy's Dr. Sharon Malone and Today's Maria Shriver Talk about MHT - The Women's Health Initiative Study
- Watch Alloy on The Today Show! - The WHI Study and Public Reaction
- Menopause Hormone Guide: Expert Insights
- NAMS Issues Updated Guidelines on Hormones
- Estrogen Alone Tied to Lower Breast Cancer Risk in UK Study
- Menopause and Breast Cancer: Dr. Bluming's Guide